Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 2133 results found. Search for [ Indian pharma ]

Results 40 to 60 of 2133
BusinessToday.In
December 24, 2019
Share Market Update: Domestic indices Sensex and Nifty edged lower on Tuesday and fell 0.45% each by the closing bell today.


BusinessToday.In
December 23, 2019
Stocks in the news: Jet Airways, Syndicate Bank, Canara Bank, IRCTC, JSW Energy, Hindalco, L&T Finance Holdings among others are the top stocks to watch out for Tuesday's trading session


BusinessToday.In
December 23, 2019
Share Market Update: Domestic indices BSE Sensex and NSE Nifty traded on a bearish note and closed lower on Monday.


PTI
December 22, 2019
Chhattisgarh has become a land of 3 Ps -- potential, prosperity and possibility, Chief Minister Bhupesh Baghel said


BusinessToday.In
December 20, 2019
Catch top stories from the world of business and economy with BusinessToday.In end of day report


Joe C Mathew
December 20, 2019
The stakeholders' dialogue with BJP, which started on Thursday, will go on till 14th January 2020. The 11 sectoral dialogues will cover areas like GST, agriculture, MSME, real estate, pharma, heavy industries, telecommunication and IT, financial sector, and macro economy in general


BusinessToday.In
December 20, 2019
Share Market Update: Benchmark indices Sensex and Nifty ended the week on a bullish note and closed in the green on Friday.


BusinessToday.In
December 19, 2019
Share Market Update: Domestic key indices BSE Sensex and NSE Nifty rallied to claim new lifetime highs on Thursday and closed higher for the seventh straight session


E Kumar Sharma
December 18, 2019
Industry watchers, however, say that it may lead to some pharma players opting more for medicines not falling under the drug price control regime


BusinessToday.In
December 18, 2019
Share Market Update: During the day, Sensex hit a record high of 41,614 and Nifty rose to 12,237, a fresh peak for the index


PB Jayakumar
December 17, 2019
According to the report 'India: the emerging hub for biologics and biosimilars', the Indian pharmaceutical companies have launched 123 biosimilars and currently have 201 active biosimilars covering multiple indications in the development pipeline


BusinessToday.In
December 17, 2019
Share Market Update: Sensex rose to its lifetime high of 41,401 in Tuesday's trade, NSE Nifty cliamed a all-time high of 12,182 today


BusinessToday.In
New Delhi, December 16, 2019
Anti-diabetic drug Vildagliptin has witnessed a strong uptake in India for the last couple of years and are currently available across the country


BusinessToday.In
December 16, 2019
Stocks in the news: YES Bank, Cipla, Magma Fincorp, JM Financial, Shriram Transport among others are the top stocks to watch out for Tuesday's trading session


BusinessToday.In
December 16, 2019
Share Market : Key benchmark indices Sensex and Nifty turned volatile and ended lower on Monday, tracking global equities


BusinessToday.In
December 16, 2019
Share Market LIVE: Key benchmark indices have started Monday on a record high note, with Sensex hitting lifetime high of 41,185 on BSE and Nifty hovering near all-time high of 12,158 on NSE


Aprajita Sharma
Mumbai, December 13, 2019
Recognised as one of the most coveted industry awards, BT Best CEO Awards are evaluated on several business parameters including the company's growth in revenue and profit, innovation and transformational changes, impactful strategies and contribution to the nation's growth


Rupa Roy
December 13, 2019
Vedanta, Axis Bank, SBI, Hindalco and YES Bank were among the top gainers on Friday. Dr Reddy, Bharti Airtel, Kotak Bank, Zee Entertainment and Bajaj Auto were among the top losers.


BusinessToday.In
December 13, 2019
Share Market LIVE: Vedanta, Axis Bank, SBI, Hindalco and YES Bank were among the top gainers on Friday. Dr Reddy, Bharti Airtel, Kotak Bank, Zee Entertainment and Bajaj Auto were among the top losers in today's trade.


E Kumar Sharma
New Delhi, December 11, 2019
At a time when most pharma companies are cash-strapped, Divis has undertaken big capex with its cash surplus


PAGES 3 OF 107  12345